XML 57 R41.htm IDEA: XBRL DOCUMENT v3.21.1
SEGMENT REPORTING (Tables)
12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENT INFORMATION

Certain information concerning the Company’s segments is presented in the following tables (in thousands):

  

For the

Year Ended

December 31,

  

For the

Year Ended

December 31,

 
   2020   2019 
Net revenues:          
Reportable segments:          
Regenerative medicine  $3,730   $2,353 
Contract services   6,396    3,299 
Total net revenues  $10,126   $5,652 
           
Net loss:          
Reportable segments:          
Regenerative medicine  $(42,815)  $(91,259)
Contract services   (39)   (1,234)
Total net loss  $(42,854)  $(92,493)

 

   December 31, 2020   December 31, 2019 
Identifiable assets employed:          
Reportable segments:          
Regenerative medicine  $36,858   $48,615 
Contract services   8,652    4,984 
Total assets  $45,510   $53,599